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Many randomized trials are designed to collect outcomes at fixed points in times after randomized. In
practice, study participants miss their assessments or are assessed off-schedule. If and when individuals are
assessed may be informative. In this thesis, we develop a sensitivity analysis methodology for analyzing
randomized trials with a potentially informative assessment process. We develop these methods in the
context of the Asthma Research for the Community (ARC) trial.
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In many randomized trials, patients are scheduled to take assessment at fixed points in time after ran-
domization. In practice, the number and timing of outcome assessments often vary from patient to patient.
Importantly, the timing of assessments may be informative in the sense that the distribution of outcomes
at the scheduled time for those who are assessed at that time can be different than for those who miss
completely or present off-schedule.
To illustrate, consider the Asthma Research for the Community (ARC) study. ARC was a PCORI-
funded pragmatic trial, which enrolled 301 low-income individuals with uncontrolled symptoms of asthma.
[1] [2] Each participant was randomized to a control (PT) or intervention (PT + HV) group. The PT group
involves usual care plus a web-based training program, which aims to improve the relationship between a
patient and their healthcare providers. The PT + HV group adds home visits by community workers. The
study was designed to collect asthma control outcomes at 3 months, 6 months, 9 months, and 12 months
after randomization. In the PT group, 92%, 72%, 61%, and 92% of the participants completed their 3, 6,
9, and 12 asthma control questionnaires. In the PT + HV group, the corresponding percentages are 92%,
70%, 54%, and 89%. These completion rates do not accurately reflect the variability in the assessment times
relative to the targeted assessment times. Figure (1.1) shows how the actual assessment times compared to
the planned times for the PT (top panel) and PT + HV (bottom panel) groups. For both groups, we notice
that there is a tendency of delayed response for all four assessments. While the distributions of assessment
times are similar across treatment groups, this does not imply that the treatment effects, estimated using
traditional methods, will be unbiased. This is due to the potentially informative nature of data collection
and the fact that the degree of informativeness can differ between groups.
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Figure 1.1: The Density of Assessment Times by Visit, Stratified by Treatment Group.
In the presence of irregular assessment times, researchers typically create assessment windows and then
apply missing data methods. This approach is unnatural and ad-hoc as the outcomes of patients assessed
only one day apart will be treated differently: one within the window (observed) and one outside the window
(missing). Rather than dichotomizing in this fashion, a more natural approach is to treat the assessments
2
as a stochastic process that plays out over time. Towards this end, two broad classes of methods have been
proposed. The first class assumes that the assessment-time process is explainable by observable information,
i.e., the risk of being assessed at each time t is independent of the outcome at time t given the past history
of information collected prior to time t. [8][9][15][16] This assumption will be violated if participants are
more likely to be assessed at a given time based on their outcome at that time, even after accounting for
their past history. The second class posits a joint model for the outcome and assessment-time processes
using shared or dependent random effects. [4] [6] [7] [10] [17] [19] [20] [21] These methods depend on strong
distributional assumptions and induce very specific dependence structures between the two processes. Both
classes of methods depend on fundamentally untestable assumptions.
In Chapter 2, we introduce the data structure and notation. Chapter 3 discusses our modeling approach.
Chapter 4 presents a re-analysis of the ARC study. Chapter 5 is devoted to a discussion.
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Chapter 2
Data Structure and Notation
We introduce notation for a random individual. Until later, we ignore treatment assignment. For our
context, we define random variables that are indexed by time as well as their histories through time. Let Y (t)
be the outcome at time t, N(t) be the number of assessments that occur at or prior to time t and dN(t) be the
indicator of assessment at time t. Let Y obs(t) = {Y (s) : dN(s) = 1, 0 ≤ s ≤ t} and N(t) = {N(s) : 0 ≤ s ≤ t}
be the history of observed outcomes and observed assessment times through time t, respectively. We use the
t− notation below to exclude time t. We denote the history of the observed data for an individual through
time t as O(t) = (N(t), Y obs(t)). We assume that we observe n independent and identically distributed
copies of O(τ), where τ is a fixed time after the last scheduled assessment.
The goal is to use the observed data to draw inference about the mean of Y (t1), . . . , Y (tK), where




3.1 Assessment Time Processes - Assumptions
Since not all participants are assessed at the protocolized assessment times, assumptions are required.
Like the missing data literature, three assumptions have been proposed: assessment completely at random
(ACAR), assessment at random (AAR), and assessment not at random (ANAR). [7] Note that the literature
uses the “visiting” prefix, but we prefer the “assessment” prefix due to its greater generality. ACAR states
that the assessment-time process is completely unrelated to the outcome process. This implies that the
distribution of the outcome at time t is the same for those who are at assessed at t and those who are not
assessed at t, i.e.
dF (Y (t)|dN(t) = 0) = dF (Y (t)|dN(t) = 1) (3.1)
where dF (·|·) represents the conditional distribution function. AAR states that assessment at time t is
unrelated to the outcome at time t, conditional on the past history observed prior to time t. Alternatively,
AAR states that, conditional on the past history observed prior to time t, the distribution of the outcome
at time t is the same for those who are not assessed at t and those who are assessed at t. Mathematically,
we can write this assumption as:
dF (Y (t)|dN(t) = 0, O(t−)) = dF (Y (t)|dN(t) = 1, O(t−)) (3.2)
ANAR states that the outcome at time t is related to assessment at time t even after accounting for the
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past history observed prior to time t. That is, the equalities in Equations (3.1) and (3.2) above do not hold.
There is an infinite number of ANAR assumptions, making it no way to enumerate.
The AAR and ANAR assumptions are not testable from the observed data. This can be seen by inspecting
Equation (3.2). Although the distribution on the right side of the equation is, with large enough samples and
sufficient smoothness conditions, estimable from the observed data, the distribution on the left side is not.
This is because the outcome at time t is not observed for those who do not show up at that time t. Thus,
AAR is an assumption that is equating a fundamentally unknowable distribution to one that is knowable.
As a result, there is no way to test AAR. By the same logic, there is no way to test ANAR. In such settings,
sensitivity analysis is critical to assess the robustness of study conclusions to unverifiable assumptions.
3.2 Sensitivity Analysis Model
Towards this end, we propose a class of assumptions, indexed by sensitivity analysis parameters, that
include AAR and wide collection of ANAR assumptions. We build a class of assumptions using a device
called exponential tilting. [3] Specifically, we assume that
dF (Y (t)|dN(t) = 0, O(t−))
=
dF (Y (t)|dN(t) = 1, O(t−)) exp{−q(t, O(t−), Y (t);α)}
E(exp{−q(t, O(t−), Y (t);α)}|O(t−)) (3.3)
where q(t, O(t−), Y (t);α) is a specified function of its arguments that does not depend on Y (t) only when
α = 0. It is important to notice that when α = 0, Equation (3.3) reduces to Equation (3.2), i.e., AAR, and
when α 6= 0, Equation (3.3) encodes a specific ANAR assumption. When the time scale is discrete, it can
be shown that (3.3) can be re-expressed as follows:
logit{P (dN(t) = 1|O(t−), Y (t))} = h(O(t−);α) + q(t, O(t−), Y (t);α), (3.4)
where
h(O(t−);α) = logit{P (dN(t) = 1|O(t−))}+
log{E(exp{−q(t, O(t−), Y (t);α)}|O(t−))}
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In our analysis in Chapter 4, we will set
q(t, O(t−), Y (t);α) = αY (t) (3.5)
Using this sensitivity analysis function, exp(α) is interpreted as the conditional (on past history) odds
ratio of being assessed at time t for individuals who differ by one unit in Y (t). When α > 0 (< 0), individuals
with higher (lower) levels of Y (t) are more likely to be assessed at time t.
3.2.1 Identification







y(t)dF (y(t)|dN(t) = 1, O(t−) = o(t−)) ×
{
P (dN(t) = 1|O(t−) = o(t−)) +
exp{−q(t, o(t−), y(t);α)}P (dN(t) = 0|O(t−) = o(t−)
E(exp{−q(t, O(t−), Y (t);α)}|O(t−) = o(t−))
}
dF (o(t−)) (3.6)
This identification formula suggests that in order to estimate E[Y (t)], we need to estimate the following
quantities:
• dF (y(t)|dN(t) = 1, O(t−)) - observed outcome regression
• P (dN(t) = 1|O(t−)) - assessment process regression
• dF (o(t−))
Since dF (o(t−)) is a marginal distribution, it is natural to estimate to it empirically. We will estimate the
observed outcome and assessment process regressions using fully parametric models.
3.2.2 Observed Outcome Regression Model
In the ARC study, the primary outcome was asthma control, reflecting symptoms over the week prior
to assessment. The outcome is a count variable, taking values {0, 1, . . . , 36}. A lower value of the outcome
represents better control, with 0 indicating total control and 36 indicating extremely uncontrolled. Figure 2
displays histograms of observed asthma control scores for the PT and PT + HV groups, stratified by planned
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assessment time. It is important to note that in each figure there is a spike near zero. This suggests a model
that accommodates so-called zero-inflation.
Figure 3.1: Histogram of Observed Asthma Control Scores, Stratified by Planned Assessment Time and
Treatment Group.
There are two popular models for handling zero-inflated count data: zero-inflated Poisson (ZIP) and
zero-inflated Negative Binomial (ZINB). These models assume that the conditional distribution of Y (t)
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given dN(t) = 1 and O(t−) is of the form:
dF (y(t)|dN(t) = 1, O(t−))
=
 p(t, O(t−);β) + (1− p(t, O(t−);β))h(y(t), t, O(t−); η) y(t) = 0(1− p(t, O(t−);β))h(y(t), t, O(t−); η) y(t) = 1, 2 . . . . (3.7)
Both the ZIP and ZINB models assume
logit{p(t, O(t−);β)} = g(t, O(t−);β) (3.8)
where g(t, O(t−);β) is a specified function of its arguments and β is an unknown vector of coefficients.
The ZIP model assumes
h(y(t), t, O(t−); η) = µ(t, O(t−); η)
y(t) exp{−µ(t, O(t−); η)}
y(t)!
(3.9)
where µ(t, O(t−); η) is a specified non-negative function of its arguments and η is an unknown vector of
coefficients. Notice that (3.9) is the Poisson distribution with mean µ(t, O(t−); η).
In contrast, the ZINB model assumes
h(y(t), t, O(t−); η) = Γ(y(t) + θ(t, O(t−); η1))








θ(t, O(t−); η1) + µ(t, O(t−); η2)
)y(t)
(3.10)
where Γ(·) is the gamma function, θ(t, O(t−); η1) and µ(t, O(t−); η2) are specified non-negative functions of
their arguments and η = (η1, η2) is an unknown vector of coefficients.
Notice that (3.10) follows a Negative Binomial distribution with mean
µ(t, O(t−); η2) (3.11)
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and variance
µ(t, O(t−); η2){1 + µ(t, O(t−); η2)/θ(t, O(t−); η1)} (3.12)
The parameters of the ZIP and ZINB models are typically estimated using maximum likelihood via the
EM algorithm. [13]
Figures (3.2) presents Q-Q plots for the Poisson, ZIP and ZINB models for the observed outcomes,
stratified by treatment group. The figure shows that the ZINB model provides a superior fit.
3.2.3 Assessment Process Regression Model
To model P (dN(t) = 1|O(t−)), we will use a model of the form:
logit{P (dN(t) = 1|O(t−))} = l(t, O(t−);φ) (3.13)
where l(t, O(t−);φ) is a specified function of its arguments and φ is an unknown parameter vector.
Estimation of φ using maximum likelihood can be biased, and such bias can be amplified in the presence
of rare events. [11] [12] In particular, predicted probabilities can be overestimated. In the ARC study,
the number of individuals assessed on any given day tends to be small. Figure 3 shows the daily count of
assessments for the PT (top panel) and PT + HV (bottom panel) groups. From the figure, we notice that
the maximal number of daily assessments are 17 and 20 in PT and PT + HV groups, respectively. Most of
the days have less than five assessments.
One way to correct this bias is to estimate φ using Firth’s method. [5] Firth’s method uses Jeffreys
invariant prior to penalizing the logistic regression likelihood function. This penalization helps to correct
bias to the first order. [5] Further improvement can be achieved by using the following FLAC procedure
proposed by [14]:
1. Estimate φ using Firth’s method;
2. Compute the hat matrix, which provides a measure of leverage hi for each observation i;
3. Create a new stacked dataset with three parts:
(a) Original outcome, original covariates, a new covariate taking on the value 0 for each observation
and an individual-specific weight equal to hi ;
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Figure 3.2: Q-Q Plots for Poisson Regression, ZIP and ZINB Models for Observed Outcomes, Stratified by
Treatment Group
(b) Original outcome, original covariates, a new covariate taking on the value 1 for each observation
and an individual-specific weight equal to hi/2 ;
(c) Reverse coding of original outcome (1 to 0; 0 to 1), original covariates, a new covariate taking on
the value 1 for each observation and an individual-specific weight equal to hi/2 ;
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Figure 3.3: Daily Count of Assessments, Stratified by Treatment Group
4. Use the stacked dataset to estimate φ using weighted maximum likelihood.
FLAC works by ensuring that the average predicted probability is close to the observed proportion of
events. It also moves the log odds ratios closer to 0 as compared to the classic logistic regression model. [14]
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3.2.4 Estimation of E[Y (t)]
Let β̂ and η̂ be the estimators of β and η, the parameters of the observed outcome regression model. Let
φ̂ be the estimator of φ, the parameter of the assessment process regression model. Using (3.6), estimation
of E[Y (t)] proceeds by iterating the following procedure:
1. Draw o(t−) from the empirical distribution of O(t−);
2. Use φ̂ to estimate the probability that dN(t) = 1 given O(t−) = o(t−); call the resulting probability
P̂ (dN(t) = 1|O(t−) = o(t−))
3. Use β̂ and η̂ to drawK y(t)’s from the estimated distribution of Y (t) givenN(t) = 1 andO(t−) = o(t−);
denote these draws by yk(t), k = 1, . . . ,K. Estimate
E(exp{−q(t, O(t−), Y (t);α)}|dN(t) = 1, O(t−) = o(t−)) by







4. Use β̂ and η̂ to draw one y(t) from the estimated distribution of Y (t) given N(t) = 1 and O(t−) = o(t−);
denote this draw by ŷ(t) and compute
ŷ(t){P̂ (dN(t) = 1|O(t−) = o(t−))
+
{1− P̂ (dN(t) = 1|O(t−) = o(t−))} exp{−q(t, o(t−), ŷ(t);α)}
Ê(exp{−q(t, O(t−), Y (t);α)}|dN(t) = 1, O(t−) = o(t−))
} (3.14)
Steps 1 to 4 are repeated J times and the results from Equation (3.14) are averaged.
The procedure is called the G-computation algorithm. This method was first introduced by James Robins
in 1986. [18]
3.2.5 Treatment Comparison
The above models and associated estimation procedures will be employed separately by treatment arm.
For combinations of treatment-specific sensitivity analysis parameters, confidence intervals for the difference
in asthma control means (PT + HV minus PT) will be computed using non-parametric bootstrap (separate




To describe the analysis of the ARC study, we introduce the following notation. Let κ(t, O(t−)) =
max{s : dN(s) = 1, 0 ≤ s < t} and Ylag(t) = Y (κ(t, O(t−)). In the observed outcome regression model, we
let
g(t, O(t−);β) = s(Ylag(t);β)
log{θ(t, O(t−); η1)} = s(t; η1,1) + s(t− κ(t, O(t−)); η1,2) + s(Ylag(t); η1,3)
log{µ(t, O(t−); η2)} = s(t; η2,1) + s(t− κ(t, O(t−)); η2,2) + s(Ylag(t); η2,3)
where s(·; ·) is a natural cubic spline function with 3 degrees of freedom, η1 = (η1,1, η1,2, η1,3) and η2 =
(η2,1, η2,2, η2,3). For the assessment regression model, we let
l(t, O(t−);φ) = s1(t;φ1) + s2(t− κ(t, O(t−));φ2) + s3(Ylag(t);φ3)
where φ = (φ1, φ2, φ3). In our model, s1(·; ·) has 5 degrees of freedom, s2(·; ·) has 10 degrees of freedom, and
s3(·; ·) has 3 degrees of freedom. We fit the ZINB model by using the R function zeroinfl from the pscl
package. We fit the FLAC method using the logistf function in the logistf package.
To assess goodness of fit, we used the estimated models to simulate, for each treatment group, a simulated
dataset with 2000 individuals. Figure (4.1) displays cumulative distribution functions of simulated and
observed asthma control scores for the four assessment times, stratified by treatment group. The figures
show a reasonable fit, except possibly for the second assessment in the PT + HV group. Figure (4.2)
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displays simulated versus observed densities of first, second, third, and fourth assessment times, stratified
by treatment group. The goodness of fit is also reasonable but appears to be better for the PT group than
the PT + HV group.
Figure 4.1: Cumulative Distribution Functions for Simulated and Observed Asthma Control Scores by
Assessment Time, Stratified by Treatment Group
Figure (4.3) displays treatment-specific estimates of the mean asthma control as a function of time since
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Figure 4.2: Simulated versus Observed Densities of First, Second, Third and Fourth Assessment Times,
Stratified by Treatment Group
randomization for various choices of α. Notice that the means decrease with α. This makes sense because
positive values of α imply that individuals with worse asthma control are more likely to be assessed at any
time t, above and beyond the past history. The figure also shows the observed means for the asthma control
scores that were categorized as 3, 6, 9, and 12 months, as in Figure (1.1). These means are similar to those
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estimated under AAR.
Figure 4.3: Estimated Mean Asthma Control Score by Time for Various Choices of α, Stratified by Treatment
Group
Table (4.1) displays the results of the naive analysis that compares treatments with respect to the observed
means for the asthma control scores at four assessments. Based on this analysis, there is no evidence of a
treatment difference.
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Table 4.1: Treatment Comparison Based on Naive Analysis
Table 4.2: Treatment Comparisons for Various Combinations of Treatment-Specific Sensitivity Analysis
Parameters at 90 Days
Tables (4.2) - (4.5) present treatment comparisons for various combinations of treatment-specific sensi-
tivity analysis parameters, for 90, 180, 270 and 360 days, respectively. As with the naive analysis, analyses
conducted assuming AAR holds in both groups (i.e. α = 0) provide no evidence of a treatment effect. If,
however, there are differential informative assessment mechanisms across the two treatment arms, there is
evidence of a difference in mean asthma control between groups; the direction of the difference depends on
the difference in signs of the treatment-specific α’s. There is no evidence to suggest a differential informa-
tive assessment mechanism across two treatment arms. Thus, this analysis does not allow us to conclude a
difference between asthma control groups.
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Table 4.3: Treatment Comparisons for Various Combinations of Treatment-Specific Sensitivity Analysis
Parameters at 180 Days
Table 4.4: Treatment Comparisons for Various Combinations of Treatment-Specific Sensitivity Analysis
Parameters at 270 Days
Table 4.5: Treatment Comparisons for Various Combinations of Treatment-Specific Sensitivity Analysis




In this thesis, we introduced a sensitivity analysis methodology for evaluating the effect of treatment in
randomized trials in the presence of potentially informative assessment times. We developed this methodol-
ogy within the context of the Asthma Research for the Community (ARC) study. In applying the method-
ology, we addressed two key challenges: zero-inflated outcomes and rare events.
The methodology relies on the specific of treatment-specific sensitivity analysis parameter. This param-
eter is interpreted as a regression coefficient in a logistic regression model. Ideally, the range of plausible
values of these parameters needs to be specified in conjunction with subject matter experts. This can be a
difficult exercise and is best executed prior to data analysis.
A key limitation of our approach is its reliance on fully parametric models. It would be useful to develop
a semiparametric extension of our methodology. It would also be useful to extend the methodology to allow
the inclusion of auxiliary covariates.
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EDUCATION
Bloomberg School of Public Health,
Johns Hopkins University Sep. 2018 - Present
Sc.M. in Biostatistics.
Academic Advisor: Elizabeth, Colantuoni, PhD.
Thesis Advisor: Daniel Scharfstein, ScD.
Overall GPA: 3.96/4.0.
Fudan University, Shanghai, China Sep. 2014 - Jul. 2018
B.S. in Mathematics & Applied Mathematics. Advisor: Qihong Xie, PhD.
Overall GPA: 3.71/4.0 Rank: 7/141.
RESEARCH AND PUBLICATION EXPERIENCE
Analysis of Randomized Trials with Missing Data Jun. 2019 - Present
Bloomberg School of Public Health, Johns Hopkins University
Advisor: Daniel Scharfstein, ScD Baltimore, MD
· Explored the use of single-hidden-layer neural networks for the analysis of randomized trials
with non-monotone missing outcome data.
Modeling Delayed Response Patterns in a Randomized Trial Dec. 2019 - Present
Bloomberg School of Public Health, Johns Hopkins University
Advisor: Daniel Scharfstein, ScD Baltimore, MD
· Modeled the informative delayed response to a series of questionnaires scheduled in a pragmatic
randomized trial by applying regression models, including the Zero-Inflated Negative Binomial
(ZINB) model and the Firth’s Logistic regression model with Added Covariate (FLAC).
Development of Brain Surgery Software Sep. 2017 - Feb. 2018
Columbia University Department of Psychiatry
Advisor: Dongrong Xu, PhD New York, NY
· Tidied and wrangled the data of brain tumor location from MRI (Magnetic Resonance Imaging)
scans.
· Developed brain surgery software seeking feasible paths of laser surgery equipment with MAT-
LAB and Python.
Mutualism Effects of Software Companies May 2017 - Oct. 2017
Fudan University School of Management
Advisor: Weihui Dai, PhD Shanghai, China
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· Implemented ecological mutualism models on the collaboration behavior of software companies
based on their spatial distribution in an industrial park in Shanghai.
· Publication: Wang, Z., Hu, X., Hu, H. (2017). Analysis of Allee Effects on Spatial Distribution
of Software Enterprises. Asian Journal of Information and Communications.: 9(2): 118 – 130.
Big Data Analysis of Cosmetics Marketing Jun. 2017 - Sep. 2017
Fudan University School of Management
Advisor: Weihui Dai, PhD Shanghai, China
· Predicted cosmetics market volume by implementing general linear models (PCA, Linear Re-
gression, etc.) on millions of transaction records using dynamic weather data.
· Designed and tested practical tools for a cosmetics enterprise (LOHTO Inc.) to improve its
future promotion plans based on the prediction of the cosmetics market.
· Publication: Wang, Z., Wu, T., Zhao, X., Cheng, S., Dai, G., Dai W. (2017). Big Data
Analysis of Weather Condition and Air Quality on Cosmetics Marketing. J. Inf. Technol.
Appl. Manag.: 24(3): 95 – 105.
TEACHING ASSISTANT AND RESEARCHING INTERNSHIP EXPERIENCE
Bloomberg School of Public Health,
Johns Hopkins University Sep. 2019 - Present
Teaching Assistant Baltimore, MD
· Served as a teaching assistant for a series of master’s level probability and statistical theory
courses in the department of biostatistics. (Essentials of Probability and Statistical Inference I-
II: PH.140.646.01 and PH.140.647.01)
· Provided academic support for first-year biostatistics Sc.M. students by grading homework and
offering TA office hours on-demand.
· Presented weekly one-hour TA-hosted lab sessions for first-year biostatistics Sc.M. students.
The Major Extremity Trauma
Research Consortium (METRC) Sep. 2019 - Present
Research Assistant
Advisor: Craig Remenapp, Senior Study Manager Baltimore, MD
· Conducted exploratory data analysis for fatal traumatic events on factors such as the type of
injury, distance to the closest trauma center, comorbidities, etc.
· Classified cases with fatal traumatic events on possible survivability under ideal conditions and
restored scenes where the fatal events had occurred based on medical reviewers’ assessments.
HONORS & AWARDS
The Kocherlakota Award for outstanding performance
in the first-year comprehensive examination Sep. 2019
Honored Graduate of Shanghai (6 in 141) Jun. 2018
National Academic Scholarship of China (2 in 141) Nov. 2017
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Excellent Group Award in Shing-Tung Yau College Mathematics Contest Jun. 2017
Excellent Student Prize of Fudan University Oct. 2016
Freshman Academic Scholarship of Fudan University Jan. 2015
SKILLS & QUALIFICATIONS
Mathematics & Statistics: Probability, Statistical Theory, Biostatistical Methods
Programming: R, MATLAB, Python, LaTeX, C/C++
Test Scores: TOEFL: 114, GRE: 159/170 (AW 4.0)
Languages: Mandarin Chinese (native), English (fluent)
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